Identification of single nucleotide variants in SLC26A9 gene in patients with cystic fibrosis (p.Phe508del homozygous) and its association to Orkambi® (Lumacaftor and Ivacaftor) response in vitro
Author:
Publisher
Elsevier BV
Subject
Genetics,General Medicine
Reference50 articles.
1. A method and server for predicting damaging missense mutations;Adzhubei;Nat. Methods,2010
2. Pleiotropic modifiers of age-related diabetes and neonatal intestinal obstruction in cystic fibrosis;Aksit;Am. J. Hum. Gene,2022
3. Development of novel therapeutics for all individuals with CF (the future goes on);Amaral;J. Cyst. Fibros.,2022
4. SLC26A9-mediated chloride secretion prevents mucus obstruction in airway inflammation;Anagnostopoulou;J. Clin. Invest.,2012
5. Characterization of SLC26A9 in patients with CF-like lung disease;Bakouh;Hum. Mutat.,2013
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The solute carrier family 26 member 9 modifies rapidly progressing cystic fibrosis associated with homozygous F508del CFTR mutation;Clinica Chimica Acta;2024-07
2. In utero and postnatal ivacaftor/lumacaftor therapy rescues multiorgan disease in CFTR-F508del ferrets;JCI Insight;2024-04-22
3. Epidemiological Profile of Hospitalized Patients with Cystic Fibrosis in Brazil Due to Severe Acute Respiratory Infection during the COVID-19 Pandemic and a Systematic Review of Worldwide COVID-19 in Those with Cystic Fibrosis;Healthcare;2023-07-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3